French Biotech Stocks

Sanofi

Market Cap: €96.7b

Engages in the research, development, manufacture, and marketing of therapeutic solutions.

Sartorius Stedim Biotech

Market Cap: €17.6b

Engages in the production and sale of instruments and consumables for the biopharmaceutical industry worldwide.

Eurofins Scientific

Market Cap: €11.0b

Provides various analytical testing and laboratory services worldwide.

Ipsen

Market Cap: €9.5b

Operates as a biopharmaceutical company worldwide.

Virbac

Market Cap: €2.6b

Manufactures and sells a range of products and services for companion and farm animals in Europe, North America, Latin America, East Asia, India, Africa, the Middle East, and the Pacific.

Vetoquinol

Market Cap: €890.6m

A veterinary pharmaceutical company, designs, develops, and sells veterinary drugs and non-medicinal products in Europe, the Americas, and the Asia Pacific region.

Valneva

Market Cap: €766.9m

A specialty vaccine company, develops, manufactures, and commercializes prophylactic vaccines for infectious diseases with unmet needs.

MedinCell

Market Cap: €745.3m

A pharmaceutical company, develops long acting injectables in various therapeutic areas in France.

Boiron

Market Cap: €491.4m

Manufactures and sells homeopathic medicines in France, rest of Europe, North America, and internationally.

Euroapi

Market Cap: €288.1m

Develops, manufactures, markets, and distributes active pharmaceutical ingredients and intermediates used in the formulation of medicines for human and veterinary use in France, Europe, Rest of Europe, North America, the Asia Pacific, and internationally.

Eurobio Scientific Société anonyme

Market Cap: €255.4m

Engages in the design, development, and commercialization of in vitro diagnostics products in the areas of transplantation, immunology, infectious diseases, life-science, and cancer.

Cellectis

Market Cap: €222.0m

A clinical stage biotechnological company, develops products based on gene-editing with a portfolio of allogeneic chimeric antigen receptor T-cells product candidates in the field of immuno-oncology and gene therapy product candidates in other therapeutic indications.

Genfit

Market Cap: €154.7m

A late-stage biopharmaceutical company, discovers and develops drug candidates and diagnostic solutions for metabolic and liver-related diseases.

Adocia

Market Cap: €141.9m

A clinical-stage biotechnology company, researches and develops formulations of pre-approved therapeutic proteins and peptides for the treatment of diabetes and other metabolic diseases.

OSE Immunotherapeutics

Market Cap: €140.3m

A clinical-stage biotechnology company, develops immunotherapies in the areas of immune-oncology and immune-inflammation in France and internationally.

Eurofins-Cerep

Market Cap: €91.8m

Provides various drug discovery services to pharmaceutical, biopharmaceutical, and biotechnology companies France and internationally.

Oncodesign Société Anonyme

Market Cap: €99.4m

Oncodesign Société Anonyme, a biopharmaceutical company, conducts research and development work on new therapeutic and diagnostic tools with pharmaceutical firms, biotech companies, public research institutions, and investment groups.

MaaT Pharma

Market Cap: €66.0m

A late-stage clinical company, engages in the development of gut microbiome-driven therapies to modulate the immune system and improve cancer survival.

Novacyt

Market Cap: €32.3m

Develops, manufactures, and commercializes a range of molecular assays and instrumentation to deliver workflows and services for human health, animal health, and environmental sectors.

Nicox

Market Cap: €30.7m

Operates as an ophthalmology company in France and internationally.

genOway Société anonyme

Market Cap: €28.1m

A biotechnology company, engages in the development and commercialization of custom genetically modified mouse, rat, and cell line models worldwide.

Pherecydes Pharma Société anonyme

Market Cap: €14.4m

Pherecydes Pharma Société anonyme develops antibacterial treatments based on the use of bacteriophage viruses or phages.

Valbiotis

Market Cap: €12.7m

Engages in the research and development of dietary supplements to prevent metabolic and cardiovascular diseases in France.

Aton

Market Cap: €6.4m

Operates as a bioscience company in France.

IntegraGen

Market Cap: €1.1m

Provides researchers with sequencing solutions, data management tools, and biostatistical, and bioinformatics support services in France.

Neovacs

Market Cap: €94.6k

A biotechnology company, focuses on the development of therapeutic vaccines for the treatment of autoimmune, inflammatory, allergy, and cancer diseases in France.